FOXP3 and Friedreich ataxia: Furthermore, adoptive transfer studies show that infusion of Foxp3+ CD4+ Tregs results in decreased serum mMCP-1 levels in a FA model [75], indicating that constitutive Foxp3+ CD4+ Tregs are sufficient to modulate the efferent phase of allergic reactions mediated by mast cells.